GlassScriptPhysician profile
William Hunter Garrett
NPI 1285081463
$1,221.37
in general payments reported to CMS, 2019-2025
13 companies · $15.12 in 2025
The $15.12 reported for 2025 was less than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46.06 · 2020: $124 · 2021: $92.85 · 2022: $115 · 2023: $681 · 2024: $147 · 2025: $15.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $545 · Food and Beverage: $298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $545.40 |
| Food and Beverage | $298.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $569.11 | 2023-2024 | Iovera, Zilretta |
| Ferring Pharmaceuticals INC. | $208.83 | 2021-2025 | Euflexxa |
| Arthrex, INC. | $124.07 | 2020 | |
| Trice Medical, INC. | $82.61 | 2023-2024 | |
| Pacira Therapeutics, INC. | $61.05 | 2019-2021 | |
| Heron Therapeutics, INC. | $34.70 | 2021-2022 | |
| Radius Health, INC. | $34.00 | 2022 | |
| Nalu Medical, INC. | $24.33 | 2024 | Nalu Neurostimulation System |
| Sanofi-Aventis U.S. LLC | $20.60 | 2019 | |
| Medtronic, INC. | $19.87 | 2023 | Intellis Adaptivestim |
| Amgen INC. | $18.51 | 2024 | Evenity, Prolia |
| Horizon Therapeutics Plc | $11.93 | 2021 | |
| Smith+Nephew, INC. | $11.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Garrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.